Upgrade to SI Premium - Free Trial

Canaccord Genuity Downgrades Zimmer Biomet (ZBH) to Hold

February 7, 2022 5:30 PM
Canaccord Genuity analyst Kyle Rose downgraded Zimmer Biomet (NYSE: ZBH) from Buy to Hold with a price target of $125.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades

Next Articles